Market Cap (In KRW)
108.84 Billion
Revenue (In KRW)
78.05 Billion
Net Income (In KRW)
-20.94 Billion
Avg. Volume
3133.00
- Currency
- KRW
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 15200.0-27550.0
- PE
- -
- EPS
- -
- Beta Value
- -0.235
- ISIN
- KR7003120003
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Mr. Seok-geun Yoon
- Employee Count
- -
- Website
- https://www.ilsung-ph.co.kr
- Ipo Date
- 2000-01-04
- Details
- Ilsung Pharmaceuticals Co., Ltd. operates as a pharmaceutical company in South Korea. Its products include antibiotics, analgesics, muscle relaxants, anti-coagulants, circulatory system drugs, contrast agents, diabetes treatments, digestive system medicines, anti-virals, anti-emetics, respiratory treatments, anesthetics, antipyretics, and cardiovascular system products. Ilsung Pharmaceuticals Co., Ltd. was founded in 1954 and is headquartered in Seoul, South Korea.
More Stocks
-
1452
-
1OJ
-
VEDLVedanta Limited
VEDL
-
TOKIF
-
BSPDY
-
4477BASE, Inc.
4477
-
T1LS IMMO AG
T1L
-
SPCG-RSPCG Public Company Limited
SPCG-R